Prelude Capital Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-564,244
| Closed | -$26.1M | – | 1812 |
|
|
2019
Q2 | $26.1M | Buy |
+564,244
| New | +$26.1M | 1.29% | 7 |
|
|
2019
Q1 | – | Sell |
-1,927
| Closed | -$27K | – | 1923 |
|
|
2018
Q4 | $27K | Sell |
1,927
-5,281
| -73% | -$74K | ﹤0.01% | 896 |
|
|
2018
Q3 | $110K | Buy |
7,208
+3,693
| +105% | +$56.4K | 0.01% | 655 |
|
|
2018
Q2 | $59K | Sell |
3,515
-42,737
| -92% | -$717K | ﹤0.01% | 848 |
|
|
2018
Q1 | $755K | Buy |
46,252
+8,758
| +23% | +$143K | 0.05% | 294 |
|
|
2017
Q4 | $480K | Buy |
37,494
+33,517
| +843% | +$429K | 0.04% | 384 |
|
|
2017
Q3 | $49K | Buy |
3,977
+701
| +21% | +$8.64K | ﹤0.01% | 1006 |
|
|
2017
Q2 | $27K | Buy |
+3,276
| New | +$27K | ﹤0.01% | 1087 |
|
|
2016
Q3 | – | Sell |
-25,200
| Closed | -$90K | – | 1869 |
|
|
2016
Q2 | $90K | Buy |
25,200
+12,200
| +94% | +$43.6K | 0.01% | 756 |
|
|
2016
Q1 | $38K | Buy |
13,000
+1,200
| +10% | +$3.51K | 0.01% | 947 |
|
|
2015
Q4 | $50K | Buy |
+11,800
| New | +$50K | 0.01% | 984 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1844 |
|
|
2015
Q2 | – | Sell |
-4,400
| Closed | -$32K | – | 2102 |
|
|
2015
Q1 | $32K | Buy |
+4,400
| New | +$32K | ﹤0.01% | 1586 |
|
|
2014
Q3 | – | Sell |
-30,200
| Closed | -$138K | – | 2110 |
|
|
2014
Q2 | $138K | Buy |
30,200
+19,900
| +193% | +$90.9K | 0.02% | 805 |
|
|
2014
Q1 | $48K | Buy |
+10,300
| New | +$48K | 0.01% | 1168 |
|